Appearance of paoproteins of pulmonary surfactant in human amniotic fluid
- PMID: 1242387
- DOI: 10.1152/jappl.1975.39.5.735
Appearance of paoproteins of pulmonary surfactant in human amniotic fluid
Abstract
We have isolated and partially characterized the protein found in surface-active material from adult human lungs, and have determined the time of appearance of this protein in amniotic fluid. Fluids were drawn at gestational ages from 12 to 44 wk, and were assayed for their concentration of apoprotein by an agglutination immunoassay. Surfactant apoprotein ((defined as that protein which is reproducibly found in purified preparations of surface active material) was usually first detected from 30 to 32 wk gestation, and its concentration increased almost fivefold to a maximum at 37 wk. The change in apoprotein concentration was approximately paralleled by the change in phospholipid concentration. At all gestational ages there was wide variability in both phospholipid and apoprotein concentrations, and the time of appearance of the apoprotein in amniotic fluid differed among fetuses. The results suggest that the presence of surfactant apoprotein in amniotic fluid is coincident with the biochemical and morphological maturation of the fetal lung, and are additional evidence that this apoprotein is cosecreted with the lipids of surface-active material.
Similar articles
-
[Assessment of fetal lung maturity by immunological measurement of fetal pulmonary surfactant apoproteins in amniotic fluid (author's transl)].Nihon Sanka Fujinka Gakkai Zasshi. 1982 Jul;34(7):889-98. Nihon Sanka Fujinka Gakkai Zasshi. 1982. PMID: 6809865 Japanese.
-
Deficient lung surfactant apoproteins in amniotic fluid with mature phospholipid profile from diabetic pregnancies.Am J Obstet Gynecol. 1984 Jan 1;148(1):48-53. doi: 10.1016/s0002-9378(84)80031-9. Am J Obstet Gynecol. 1984. PMID: 6546325
-
Improved immunoassay for the determination of surfactant protein A (SP-A) in human amniotic fluid.Tohoku J Exp Med. 1989 Mar;157(3):269-78. doi: 10.1620/tjem.157.269. Tohoku J Exp Med. 1989. PMID: 2658201
-
Comparison of lipids and apolipoproteins in amniotic fluid, neonatal urine, and cord serum.Ann Clin Lab Sci. 1982 Jul-Aug;12(4):288-95. Ann Clin Lab Sci. 1982. PMID: 6814342 Review.
-
Pulmonary surfactant and amniotic fluid lipids.Obstet Gynecol Annu. 1976;5:71-102. Obstet Gynecol Annu. 1976. PMID: 824585 Review. No abstract available.
Cited by
-
Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.Ther Deliv. 2013 Aug;4(8):951-80. doi: 10.4155/tde.13.72. Ther Deliv. 2013. PMID: 23919474 Free PMC article. Review.
-
Function and regulation of expression of pulmonary surfactant-associated proteins.Biochem J. 1991 Jan 15;273(Pt 2)(Pt 2):249-64. doi: 10.1042/bj2730249. Biochem J. 1991. PMID: 1991023 Free PMC article. Review. No abstract available.
-
Biochemical composition of adult human lung surfactant.Lung. 1982;160(4):195-206. doi: 10.1007/BF02719293. Lung. 1982. PMID: 6896735 No abstract available.
-
Bronchoalveolar lavage proteins.Klin Wochenschr. 1985 Sep 2;63(17):781-7. doi: 10.1007/BF01732281. Klin Wochenschr. 1985. PMID: 4057910 Free PMC article.
-
Preventing Respiratory Viral Diseases with Antimicrobial Peptide Master Regulators in the Lung Airway Habitat.Clin Pract. 2023 Jan 16;13(1):125-147. doi: 10.3390/clinpract13010012. Clin Pract. 2023. PMID: 36648852 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources